Pacific Edge share price halves after decision

https://www.odt.co.nz/sites/default/files/styles/odt_story_opengraph_1200w/public/story/2025/01/poster-home-3_2x.jpg?itok=cV6k4bSr

PHOTO: SUPPLIED A Dunedin-based cancer diagnostics company's share price halved after a decision by a United States healthcare provider to revoke coverage for its flagship product.

×